News & Events

Our news posts are an easy way to keep up-to-date with all our latest developments. View the event posts to stay informed of all our upcoming events and activities.

Delix Therapeutics partners with Cellectricon, Expressive Neuroscience and expands science team to accelerate drug discovery and translatability

We’re excited to be working with Delix Therapeutics and support their development of neuroplasticity-promoting therapeutics! At Cellectricon, we solve our...

Cellectricon strengthens IP portfolio – Receives “Intention to Grant” from the European Patent Office

Cellectricon AB, a leading provider of neurobiology in vitro research services, today announced that the company received notice of intention...

Cellectricon receives funding from Takeda’s open innovation platform

March 3, 2021 Cellectricon, a leading provider of neurobiology in vitro research services, is delighted to announce the initiation of...

Sign up to get news & events updates from Cellectricon

Dr. Christian Vægter joins Cellectricon’s advisory board

Cellectricon has appointed Dr. Christian Vægter, Associate Professor and research group leader at Aarhus University, to its Scientific Advisory Board....

Dr. Franziska Denk joins Cellectricon’s advisory board

Cellectricon has appointed Dr. Franziska Denk, Lecturer at the Wolfson Centre for Age-Related Diseases, King’s College London, to its scientific...

Advancing pain research through scientific exchange

During the current COVID-19 pandemic many of our fellow researchers see disruption in their work and are prevented from sharing...

Sign up to get news & events updates from Cellectricon

Cellectricon’s new neuroinflammation discovery services offer advanced insight into chronic pain

Mölndal, Sweden Cellectricon, a collaborative services provider dedicated to advancing drug discovery and research in the areas of chronic pain...

COVID-19 update from Cellectricon

In light of the COVID-19 pandemic, we wish to inform you that we remain open for business and are progressing the...

Cellectricon and StressMarq Biosciences collaborate to develop next generation reagents and assays to advance neurodegenerative disease research

Mölndal, Sweden and Victoria, BC, Canada Cellectricon, a collaborative services provider dedicated to advancing drug discovery and research in the...

1 2 3 4 5 … 8